|
||||||
|
Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Ongoing Earnings Growth Outlook for 2010 Abbott today announced financial results for the second quarter ended June 30, 2010. NexMed Announces Pre-Clinical Results Showing That Its Proprietary Calcipotriene Betamethasone Psoriasis Formulation … SAN DIEGO—-NexMed, Inc. , a specialty CRO with a pipeline of products based on the NexACT® technology, today announced results from a pre-clinical study showing that calcipotriene 0.005% and betamethasone dipropionate 0.064%, when formulated with NexACT®, results in a topical treatment which [...] Revotar presents positive results in Phase IIa Ozone Study with Bimosiamose for COPD HENNIGSDORF–(Marketwire – May 18, 2010) – Revotar Biopharmaceuticals AG / Revotar presents positive results in Phase IIa Ozone Study with Bimosiamose for COPD processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. |
 |
|||||
|
Copyright © 2012 PSORIASIS TREATMENT - All Rights Reserved |
||||||
Recent Comments